James Sigler

Director, CMC at Concerto Biosciences

Jim has been developing drugs for over 30 years, building CMC roadmaps that integrate with Clinical, Financial, Quality, and Regulatory to ensure that strategy, team development, systems build-out, and subsequent execution all march together. Jim is developing strategy and building infrastructure aligned with Concerto’s goal of initiating first-in-human studies. Jim has been working in the microbiome space for over six years, leading manufacturing for four different programs and successfully completing a pivotal study.

Location

Boston, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Concerto Biosciences

Concerto Biosciences reinvents humanity's relationship with microbes. Concerto invented a platform to measure, in ultra-high throughput, how microbes behave in the presence of each other.


Industries

Employees

11-50

Links